University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Maxitrol eye ointment

Specialist ophthalmologist recommendation

Status: Green Measles, Mumps and Rubella vaccine, live (MMR)

Supported with PGD

Status: Red Mecasermin Increlex®

NHSE commissioned

Status: Green Medroxyprogesterone acetate (Sayana Press) 104mg in 0.65ml SC injection

Suitable for self-injection in patients who have had appropriate training

Status: Green Medroxyprogesterone acetate tablets

Provera and Climanor

Status: Red Medroxyprogesterone injection 150mg/1ml

Umbrella service only

Status: Green Mefenamic acid capsules

For dysmenorrhoea

Status: Green Mefenamic acid tablets

For dysmenorrhoea

Status: Amber Melatonin 2mg M/R tablets (Circadin®)

REM sleep behaviour disorder and circadian rhythm sleep-wake disorder in adults

Status: Amber Melatonin 3mg tablets

REM sleep behaviour disorder and circadian rhythm sleep-wake disorder in adults

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top